Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
- Medical Sciences
- Computer Science
- Economics
- Biology
- Engineering
- Business
- Science
- Education
- Materials Science
- Mathematics
- Psychology
- Arts and Literature
- Social Sciences
- Law
- Humanities
- Chemistry
- Environment
- Sports and Recreation
- Linguistics
- Philosophy
- Electrical Engineering
- Earth Sciences
- Design
- Physics
- Statistics
- 15 more »
- « less
-
, and readiness for discharge and revise plan or make referrals as necessary. Acts as a role model and mentor to a variety of students and nurses new to the unit. Functions as a (PCC) Patient Care
-
. Applications received by March 19, 2026 will receive first consideration. Applicant Resources https://www.uidaho.edu/human-resources/careers/applicant-resources Background Check Statement Applicants who
-
, and readiness for discharge and revise plan or make referrals as necessary. Acts as a role model and mentor to a variety of students and nurses new to the unit. Functions as a (PCC) Patient Care
-
/splicing, as well as the development of enhancer activity lineage-tracing approaches in stem cell and/or mouse models. We are particularly interested in candidates with expertise in transcriptional
-
Mechatronic Engineering. Our Schools QS ranking for 2025 is #46 globally and the highest in Australia. For further information on our school, go to - https://www.unsw.edu.au/engineering/our-schools/mechanical
-
Objectives: - Completion of the characterization of nanomateriais on in vivo models of vaccination - Completion of the characterization of nanomateriais on in vitro and in vivo cancer models - Analysis
-
Location Lexington, KY Grade Level 46 Salary Range $52,021-85,800/year Type of Position Staff Position Time Status Full-Time Required Education BS Click here for more information about equivalencies: https
-
-derived motor neurons and Drosophila models. Now, we need a curious and driven PhD candidate to help us analyze these samples using spatial multi-omics. This is a joint project between Prof. Albena
-
to the development and use of new in vitro model systems for neurodegenerative diseases and brain cancer. The group is led by Henrik Ahlenius and includes 3 postdocs, an associate researcher, and a number of master’s
-
management. Research, models and analyzes information for review by the investment team. Analyzes directional changes in financial markets and industries, which may affect portfolio investments. Prepares